SCHEMBL20005074

SCHEMBL20005074

Cc1c(C#Cc2ccc(N(C)CCF)cc2)[nH]c2c1=CCCN=2

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
SNCA P37840 1/20 0.43
APP P05067 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21147094 0.90 MAPT (0.33) MAPTSNCA
SCHEMBL20004640 0.86 MAPT (0.41) MAPTSNCAAPP
SCHEMBL22537754 0.74 SNCA (0.52) MAPTSNCAAPP
SCHEMBL20005141 0.70 SNCA (0.63) MAPTSNCAAPP
SCHEMBL20005163 0.66 MAPT (0.44) MAPTSNCAAPP
SCHEMBL22537542 0.63 SNCA (0.39) MAPTSNCA
SCHEMBL22537869 0.63 SNCA (0.62) MAPTSNCAAPP
SCHEMBL20004522 0.62 SNCA (0.72) MAPTSNCAAPP
SCHEMBL20004443 0.62 SNCA (0.60) MAPTSNCAAPP
SCHEMBL22537852 0.61 MAPT (0.46) MAPTSNCAAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515912-B1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NAT RECH SCIENT (FR) 2020-10-14 EP disclosed
WO-2018055316-A1 COMPOUNDS FOR USING IN IMAGING AND PARTICULARLY FOR THE DIAGNOSIS OF NEURODEGENERATIVE DISEASES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2018-03-29 WO disclosed